Company's net income grew by 15.9% over the first three months of 2020. FMTNews
PARIS: French pharmaceutical giant Sanofi said Friday that its first quarter sales surged in part due to stockpiling of the painkiller Doliprane, as other companies around the world struggle during the coronavirus pandemic.
“Covid-19 stocking in channels explains about half of company sales growth in Q1,” the company said in a statement. Sanofi said its net income grew by 15.9% over the first three months of 2020, with “roughly half of this growth due to Covid-19 impact.”
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Daimler earnings plunge as coronavirus hammers vehicle sales, production | Malay MailNEW YORK, April 23 — Daimler AG said today it expected to report a near 70 per cent plunge in a key first-quarter earnings figure and 2020 industrial free cash flow to fall, as customers shunned Mercedes-Benz car showrooms amid the novel coronavirus pandemic. The forecast provides further...
Read more »
Malaysia's Kimanis crude supply to halve in May, June - sourcesCORONAVIRUS | M'sia is part of the Opec plus group which has agreed to ease oil production to reduce a global supply glut amid the coronavirus pandemic.
Read more »
Australia urges probe into origins of coronavirus, France says not nowCORONAVIRUS | French President Emmanuel Macron says the urgency is to beat the pandemic before looking for who is at fault.
Read more »
Jakarta extends social restrictions to May 22 | The Malaysian InsightIndonesian capital has highest coronavirus death toll at 301, with 3,383 infections.
Read more »